John J.S. Cadwell
FiberCell Systems Inc USA
Mario A Bianchet
Johns Hopkins School of Medicine USA
University of Tromsø - The Arctic University of Norway Norway
Hiroshima University Japan
Glenn S Tillotson
TranScrip Partners LLC USA
Temple University School of Medicine USA
Reckitt Benckiser UK
Bangor University UK
Recommended Global Pharmaceutical Sciences Webinars & Conferences
- About Antimicrobials 2020
- Antimicrobials 2020 Sessions And Tracks
- Antimicrobials 2020 Market Analysis
- Past Conference Report
About Antimicrobials 2020
Conferences Series invites all the participants to attend “8th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance” during November 25-26, 2020, Singapore which includes prompt keynote, Oral talks, Poster presentations and Exhibitions.
Antimicrobials 2020 is a stage to look at and determine regarding the most recent progress within the field of Antibiotics and Antibiotic Resistance as the world's thought turned with respect to the anxiety of latest anti-toxins as the antimicrobial resistance is developing step by step. Numerous countries and International successful associations are enterprises to focus on the present circumstance and creating new ways to prevent the adverse effects of Antibiotic resistance.
Why to attend:
Antimicrobials 2020 is a world stage for presenting researches with reference to antibiotics, infections and exchanging ideas, contributes to the dissemination of information in Antibiotics, Antimicrobials and Antibiotics Resistance for the advantage for both the academic and business.
The organizing committee of this Antimicrobial Conference is getting ready for inspiring and explanatory conference program including Keynote talks, workshops on a variety of topics, poster presentations and various programs for participants from all over the globe. We invite you to join us at the Antimicrobials 2020, where you will be sure to have a meaningful experience with scholars from all around the world. All members of the Antimicrobials 2019 Congress and Organizing Committee look forward to meeting you in Singapore.
- Food Safety Experts
- Alliances of antibiotics
- Business Entrepreneurs
- Antibiotics Researchers
- Strategic Drug Development
- Executive Council of Global
- Directors of Pharma Industries
- Medical Affairs and Networking
- Public Health Preparedness Sectors
- Scientific Business Communications
- Antibiotics Associations & Societies
- Associate Professors
- Medical companies
- Pharmaceutical companies
Importance & Scope:
Antimicrobials 2020 is focused on the theme “Innovative and Approaches in the field of Antibiotics and Antimicrobials”. Antimicrobials 2020 is a conference designed in a way to provide an exclusive platform for upcoming researchers, scientists, students and educators to present and discuss the latest innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the microbiology field. The two days of educational program will be composed of keynote talks, session speakers, and poster presenters on the latest in innovative technologies as well as papers in the areas of Antimicrobials conferences, Antibiotic events, Antibiotic Resistance conferences, workshops on the field of microbiology.
Antimicrobials 2020 Sessions And Tracks
Antibiotics are used to treat or prevent bacterial infections and consistently protozoan infections. (Metronidazole is efficient against a number of parasitic diseases). When an infection is suspected of being responsible for an illness but the responsible pathogen has not been identified, empiric therapy is adopted. This involves the application of a broad-spectrum antibiotic occupying on the signs and a symptom presented and is initiated pending laboratory results that can take a lot of days.
Track 2: Antibiotics by Drug origin
The first economically available antibacterial was Prontosil, a sulfonamide improved by the German biochemist Gerhard Domagk in the 1930s. Before this, in 1928, Alexander Fleming had invented the first antibiotic, penicillin, but it took over a decade before penicillin was introduced as a treatment for bacterial infections. This was possible through the work of Florey and Chain who managed to purify the antibiotic and scale-up production efficiently.
Antibiotics are not the right choice for all infections. For example, most sore throats, cough and colds, flu or acute sinusitis are viral in origin (not bacterial) and do not require an antibiotic. These viral infections are “self-limiting”, meaning that your own immune system will commonly kick in and fight the virus off.
Track 5: Infection Diseases
Infectious diseases are caused by microorganisms like viruses, bacteria, fungi or parasites and may unfold between people. Infectious diseases square measure effected by microorganisms like viruses, bacteria, fungi or parasites. Microorganisms that cause un-wellness square measure conjointly specified to as pathogens. Pathogens cause un-wellness either by disrupting the body conventional processes and/or stimulating the system to provide a defensive response, leading to high fever, inflammation and different symptoms.
Environmental microbes are a leading source of drug discovery, and several microbial products ( anti-tumor products, antibiotics, immunosuppressants and others) are used frequently for human therapies. Most of these products were accessed from cultivable (<1%) environmental microbes, means that a large number of microbes were not targeted for drug discovery.
Track 7: Antibiotics and their interactions
An antibiotic is a nature of antimicrobial phenomenon effective against bacteria and is the most important category of antibacterial agents for fighting bacterial infections. Antibiotic medications are generally used in the treatment and prevention of such infections. They may either kill or inhibit the augmentation of bacteria. A limited number of antibiotics also acquire antiprotozoal activity. Antibiotics are not adequate against viruses such as the general cold or influenza; drugs that inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics.
List of Common Infections Treated with Antibiotics:
- Conjunctivitis (Pink Eye)
- Otitis Media (Ear Infection)
- Sexually Transmitted Diseases (STD’s)
- Skin or Soft Tissue Infection
- Streptococcal Pharyngitis (Strep Throat)
- Traveler’s diarrhea
- Upper Respiratory Tract Infection
- Urinary Tract Infection (UTI)
Track 8: Types of Antibiotics and importance
Most antibiotics fall into their individual antibiotic classes. An antibiotic class is a grouping of different drugs that have identical chemical and pharmacologic properties. Their chemical structures may look commensurate, and drugs within the same class may kill the same or related bacteria.
Antibiotics are generally classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those target the bacteria cell (penicillins and cephalosporins) or the cell layer (polymyxins), or prevent with necessary bacterial enzymes (rifamycins, lipiarmycins, quinolones and sulfonamides) have bactericidal actions. Protein synthesis inhibitors (macrolides, lincosamides, and tetracyclines) are generally bacteriostatic (with the omission of bactericidal aminoglycosides).
Antibiotic resistance is increased by the dissipate and overuse of antibiotics, as well as poor infection prevention and control. Steps can be taken at all levels of society to decrease the impact and limit the spread of resistance.
To prevent and control the circulate of antibiotic resistance, individuals can:
- Only use antibiotics when recommended by a certified health professional.
- Never demand antibiotics if your health worker announces you don’t need them.
- Always follow your health worker’s guidance when using antibiotics.
- Never share or use leftover antibiotics.
- Prevent infections by frequently washing hands, making healthy food, avoiding close contact with sick people, practicing safer sex, and keeping vaccinations up to date.
- Prepare healthy food, following the WHO Five Keys to Safer Food (keep clean, separate organic and cooked, cook thoroughly, place food at secure temperatures, use safe water and organic materials) and prefer foods that have been produced without the use of antibiotics for growth promotion or disease prevention in healthy animals.
Antibiotics have been tested for the treatment of autoimmune diseases for over fifty years, based on the premise that infections play a role in the initiation and propagation of these entities. The antibiotics market was valued at USD 39.8 million in 2015 and is expected to witness a CAGR of 4.0% over the forecast period.
Antibiotic resistance plays an important and influence on one’s health as treating an antibiotic-resistant infection is difficult. The management of broad-spectrum and narrow-spectrum antibiotics by patients should be resolved after good consultation with a doctor. The unwanted usage of high doses also causes genetic mutation in bacteria leading to antibiotic resistance. It has been estimated that 700,000 to several million deaths result per year as the resistance is increasing globally as exposure to antibiotic drugs has increased in developing countries.
Reasons for the comprehensive use of antibiotics in human medicine include:
- Increasing universal availability over time since the 1950s
- Uncontrolled sale in many low or middle-income countries, where they can be obtained over the counter without a prescription, potentially resulting in antibiotics being used when not indicated. This may result in the emergence of resistance in any remaining bacteria.
Other causes include:
- Antibiotic benefits in livestock feed at minor doses for improvement promotion is an accepted practice in many industrialized countries and are known to lead to increased levels of resistance.
- Releasing huge quantities of antibiotics into the environment during pharmaceutical manufacturing through incompetent wastewater treatment increases the risk that antibiotic-resistant strains will develop and extended.
- It is uncertain whether antibacterial in soaps and other products share to antibiotic resistance, but antibacterial soaps are discouraged for other reasons.
Antibiotic resistance invokes especially to the resistance to antibiotics that occurs in common bacteria that cause infection. The easy approach and capability of Antibiotics led to overuse in live-stock rising promotes bacteria to flourish resistance. This led to comprehensive problems with antibiotic resistance. World Health Organization (WHO) classified antimicrobial resistance as a serious hazard and no longer an indicator for the future.
Track 13: Antibiotics in Different Industries
Antibiotics must be used accordingly in humans and animals because of both use share with the emergence, persistence, and escalation of resistant bacteria. Resistant bacteria in food- generating animals are of particular concern. Food animals play as a cause of resistant pathogens and resistance mechanisms that can directly or indirectly result in antibiotic-resistant infections in humans.
Track 14: Applications of Antibiotics
Choice of related antibiotics is currently based on individual patient need. Preservation of bacterial sensitivity needs perceptive of how antibiotics select resistance. ‘Ten commandments’ which might be considered carefully when a preference has to be made for antibiotic prescribing.
In the prior, most drugs have been invented either by identifying the active ingredient from traditional remedies or by serendipitous discovery. A new access has been to recognize how disease and infection are controlled at the molecular and physiological level and to mark specific entities based on this knowledge. The process of drug discovery involves the identification of candidates, characterization, screening, synthesis, and assays for therapeutic efficacy.
New diseases are originating globally and old diseases are re-emerging as Infectious agents increase or spread, and changes occur in conservation, socio-economic conditions, and population patterns. Likewise, many diseases thought to be decently controlled appear to be developing a revival.
There is a renewed interest in the antibiotic sector, which is evident from the most recent patents and investments. Bacterial vaccines and new antibiotic classes are achieving an exceptional amount of attention with several product candidates in clinical development. These new products are expected to change the outlook of the antibiotic sector to a large extent over the next 5 years. Several reports focus on anti-infective markets in general. This report, however, focuses absolutely on antibacterial, with a specific emphasis on the emerging problem of antibiotic resistance. It also includes a detailed analysis of the emerging technology trends, which give a clear picture of the future of the sector.
Antibiotic overuse and misuse have led to a growing number of bacteria in humans, animals and the environment that are resistant to life-saving antimicrobial therapies. Urgent activity is needed to halt the progress of resistance, and to accelerate new treatments for bacterial infection.
Antimicrobials 2020 Market Analysis
The worldwide Antibiotics market is esteemed at $6,727.29 million in 2014 and is relied upon to develop at a CAGR of 13.03% in the vicinity of 2014 and 2019. Expanding sickness weight of irresistible maladies and expanded subsidizing for social insurance consumption are the essential development drivers for this market amid the conjecture time frame. The pharmaceuticals application fragment represented the biggest share of the Antimicrobials advertise in 2014; while the nourishment application portion is normal develop at the most astounding CAGR in the vicinity of 2014 and 2019 in the worldwide Antibiotics showcase. The global clinical antimicrobials market is projected to reach USD 5.77 Billion by 2021 from USD 3.35 Billion in 2016, growing at a CAGR of 11.5% from 2016 to 2021. Market growth can be attributed to factors such as the technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science researches.
Emerging regions such as Asia-Pacific (including Japan, China, and India) are expected to become the new revenue-generating pockets in the market in the next five years. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period owing to the growing number of hospitals and clinical diagnostic laboratories in India and China; expanding research capabilities for the development of innovative and affordable clinical Antibiotics testing procedures across India, China, and Japan; and rising incidences of infectious diseases.
Market research is vital to the development of the industrial market, and continues to be in demand. In 2018, we anticipate delivery of new editions of our report on Antimicrobials Testing in the Global spurt.
Global Market Survey:
Antimicrobials size was valued at over USD 24.3 billion in 2017 and will exceed USD 675.2 billion with 7.9% CAGR from 2017 to 2024. At Global Market Insights, It is a unique blend of primary and secondary research, with validation and iterations, in order to minimize deviation and present the most accurate analysis of the industry.
Rising demand of new technologies will drive the biotechnology industry size. we’ve seen tremendous growth and change in the industrial diagnostics industry, particularly in the food safety sector expertise in all aspects of the market, plus extensive experience in business management, strategy development and international business, Antibiotics test volumes, market values and methods used by food producers around the world, based on detailed interviews with more than 450 food production facilities in America, Europe and Asia, including Japan. Total test volumes have increased 128%, and testing for specific foodborne pathogens like Salmonella and E. coli grew at an even faster rate.
The global DNA sequencing market is projected to reach USD 85.5 Million by 2025 from USD 310.1 Million in 2017 growing at a CAGR of 8.5% during the forecast period.
The global market for Food Antibiotics reached nearly $7.1 billion in 2017. This market is expected to grow to nearly $9.6 billion in 2017 and $15.7 billion by 2025, with a compound annual growth rate (CAGR) of 8.1% from 2017 to 2025.
Global Nanotechnology Market was valued at $216.2 billion in 2017 and $448.3 billion in 2017. The total market is projected to grow at a compound annual growth rate (CAGR) of 19.3% from 2017 through 2025 and reach $828 billion by 2025.
Based on technology, the industry is segmented into tissue engineering and regeneration, fermentation, PCR, nanotechnology, chromatography, DNA sequencing and cell based assay. In 2017, the tissue engineering and regeneration segment accounted for highest revenue and was valued at over USD 11.3 billion. However, the nanotechnology, fermentation and cell based assay segments will experience lucrative growth owing to rising R&D initiatives by various biotechnological and pharmaceutical companies.
The global clinical Antimicrobials market is valued at $6,727.29 million in 2014 and is expected to grow at a CAGR of 13.03% between 2014 and 2019. Increasing disease burden of infectious diseases and increased funding for healthcare expenditure are the important growth drivers for this market during the forecast period. The pharmaceuticals application segment accounted for the largest share of the Antibiotics market in 2014, while the food application segment is expected grow at the highest CAGR between 2014 and 2019 in the global Antimicrobials market.
Several microorganisms are used in industrial Antibiotics, including laboratory-selected mutants, naturally occurring organisms, and genetically modified organisms (GMOs). Antimicrobials research and development is finding increasing application in oil and gas organizations, the food and beverage industry, and environmental testing organizations.
In addition, the traditional R&D in the biopharmaceutical industry is witnessing an upsurge, due to drug development research, which is helping in the augmentation of the industrial Antibiotics market.
Increased demand for nutraceuticals and other fermented products further drives the importance of industrial application of Antimicrobials on a large scale. Such factors are helpful to drive the industrial market.
However, in the market, there are several conflicts observed regarding the usage of genetically modified organisms in food sources, which are expected to restrict the growth of the industrial Antibiotics market.
Past Conference Report
The 7th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance, (Antimicrobials 2019) was held in Tokyo, Japan during May 20-21, 2019.
Antimicrobials 2019 has welcomed the new era of Antibiotics & Antimicrobials; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series LLC ltd was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Antibiotics & Antimicrobials, covering all the possible research areas.
The conference aimed a parallel rail with theme “Antibiotics: Discovery, Resistance, and Alternatives”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Antibiotics: an overview, Antibiotic resistance in a one-health context, Microbial virulence, Developing new drugs: academic and industrial innovations, Antibiotics, microbes and models, Antibiotics by chemical class to mention a few.
Conference Series extends its warm gratitude towards all the Participants, Eminent Speakers, Young Researchers, Delegates and Students.
We would like to specially thank the following people who laid the foundation for the event’s success.
Organizing Committee Members:
Bernhard R. Ruf - Klinikum St. Georg gGmbH, Germany
Tadashi Shimamoto - Hiroshima University, Japan
Martin Duerden - Bangor University, UK
Yasuhiro Igarashi - Toyama Prefectural University, Japan
Lidia Sas Paszt, Research Institute of Horticulture, Poland
Tadashi Shimamoto, Hiroshima University, Japan
Stef Stienstra, Dutch Armed Forces/Royal Dutch Navy, Netherlands
Ewa Solarska, University of Life Sciences in Lublin, Poland
Maulin P Shah, Enviro Technology Limited, India
Clarence M Ongkudon, University Malaysia Sabah, Malaysia
Marina Sidorenko, Federal Scientific Center of the East Asia Terrestrial Biodiversity, Russia
Mohammad Magdy El Metwally, Damanhour University, Egypt
After the huge optimistic response from the scientific fraternity, renowned personalities and the Editorial Board Members of Conference Series from across the world. We are pleased to announce the 8th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance to be held during November 25-26, 2020 at Singapore.
Let us meet again @ Antimicrobials 2020
Past Reports Gallery